Li SQ - Search Results

1

[Establishment and Analysis of Risk Prediction Model for Metabolic Dysfunction-Associated Fatty Liver Disease in Physical Examination Population].

Xia B, He H, Qin K, Li SQ, An ZM. Xia B, et al. Among authors: li sq. Sichuan Da Xue Xue Bao Yi Xue Ban. 2023 May;54(3):591-595. doi: 10.12182/20230560109. Sichuan Da Xue Xue Bao Yi Xue Ban. 2023. PMID: 37248589 Free PMC article. Chinese.

2

[The expression of glucocorticold receptor isoform in peripheral blood mononuclear cell with Graves' ophthalmopathy].

An Z, Yu N, Wei S, Xia Q, Li S, Xie Q. An Z, et al. Hua Xi Yi Ke Da Xue Xue Bao. 2002 Apr;33(2):241-3. Hua Xi Yi Ke Da Xue Xue Bao. 2002. PMID: 12575196 Chinese.

3

[The immunogenicity and effect of domestic recombinant human growth hormone: serum GH-antibody determination and evaluation].

Li S, Yu Y, An Z, Xiong Z, Yu H. Li S, et al. Hua Xi Yi Ke Da Xue Xue Bao. 2002 Jan;33(1):77-9, 83. Hua Xi Yi Ke Da Xue Xue Bao. 2002. PMID: 12599435 Chinese.

4

[Antibodies to glutamic acid decarboxylase in patients with Graves disease].

An Z, Zhao H, Li S, Zhao G. An Z, et al. Sichuan Da Xue Xue Bao Yi Xue Ban. 2003 Jan;34(1):98-9. Sichuan Da Xue Xue Bao Yi Xue Ban. 2003. PMID: 15600194 Chinese.

5

[Serum leptin, adiponectin, visfatin levels in adult GHD patients and correlation studies].

Li ZP, Zhang T, Zhou GY, Gao J, Li SQ, An ZM. Li ZP, et al. Among authors: li sq. Sichuan Da Xue Xue Bao Yi Xue Ban. 2013 Jul;44(4):588-91. Sichuan Da Xue Xue Bao Yi Xue Ban. 2013. PMID: 24059114 Chinese.

6

Dapagliflozin treatment for type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials.

Zhang M, Zhang L, Wu B, Song H, An Z, Li S. Zhang M, et al. Diabetes Metab Res Rev. 2014 Mar;30(3):204-21. doi: 10.1002/dmrr.2479. Diabetes Metab Res Rev. 2014. PMID: 24115369 Review.

7

[Blood lipid, glucose and uric acid in people with subclinical hypothyroidism].

Liang LB, Zhang M, Huang HJ, Wang YJ, Li SQ. Liang LB, et al. Among authors: li sq. Sichuan Da Xue Xue Bao Yi Xue Ban. 2013 Nov;44(6):954-6. Sichuan Da Xue Xue Bao Yi Xue Ban. 2013. PMID: 24490510 Chinese.

8

[Changes of bone mineral density and bone metabolic marker in patients with subclinical hypothyroidism].

Liang LB, Wang YJ, Zhang M, Huang HJ, Li SQ. Liang LB, et al. Among authors: li sq. Sichuan Da Xue Xue Bao Yi Xue Ban. 2014 Jan;45(1):66-9, 83. Sichuan Da Xue Xue Bao Yi Xue Ban. 2014. PMID: 24527585 Chinese.

9

[Prevalence of diabetes and impaired glucose regulation in Chengdu populations and associated dietary risk factors].

Dai H, Chen LY, Li SQ. Dai H, et al. Among authors: li sq. Sichuan Da Xue Xue Bao Yi Xue Ban. 2014 Jan;45(1):79-83. Sichuan Da Xue Xue Bao Yi Xue Ban. 2014. PMID: 24527588 Chinese.

10

[Risk stratification of diabetic chronic kidney disease using eGFR equations].

Zhou J, Zhang M, Song HL, Yang FJ, Huang HJ, Li SQ. Zhou J, et al. Among authors: li sq. Sichuan Da Xue Xue Bao Yi Xue Ban. 2014 Jan;45(1):93-6, 101. Sichuan Da Xue Xue Bao Yi Xue Ban. 2014. PMID: 24527591 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,075 results

Search Page

Filters